Experienced medtech finance executive brings extensive public company and capital markets experience to support the company’s next phase of global growth
FORT LAUDERDALE, FLORIDA, July 14, 2026 (GLOBE NEWSWIRE) — via IBN — SS Innovations International, Inc. (“The Company” or “SS Innovations”) (Nasdaq: SSII)The developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to the global population, today announced the appointment of Sara M. Romano as Chief Financial Officer, effective August 3, 2026. Ms. Romano will be based in the United States.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We are thrilled to welcome Sara as our Chief Financial Officer at this important moment in our growth journey. As we continue our global expansion, including securing US FDA approval of our advanced, cost-effective SSI Mantra Surgical Robotic System, Sara brings strong financial leadership, deep strategic vision and extensive capital markets experience. She brings strong financial leadership, deep strategic vision and extensive capital markets experience. She will lead our financial operations to accommodate our anticipated growth. “Will play an integral role in enhancing and enhancing the
“I am delighted by this opportunity to collaborate closely with Dr. Sudhir and the leadership team as SS Innovations pursues its mission to democratize global access to cutting-edge surgical robotic care,” said Ms. Romano.
Ms. Romano is an experienced public company finance executive with more than two decades of experience leading capital strategy, corporate development and financial operations in the medical technology and life sciences industries. Most recently, Ms. Romano served as Chief Financial Officer of Vicarious Surgical, a robotic surgery company, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support the company’s strategic objectives. Previously, he served as Chief Financial Officer of Entero Therapeutics and Kiora Pharmaceuticals, where he led capital raising activities, strategic transactions, SEC reporting and investor relations programs. Throughout her career, Ms. Romano has raised over $100 million through public and private financing and has extensive experience supporting emerging public companies, including robotic surgery and medical technology organizations, during periods of transformation, growth and strategic change.
Ms. Romano began her career as an auditor at PricewaterhouseCoopers and is a licensed Certified Public Accountant (CPA) in Massachusetts. He earned a Bachelor of Arts in Accounting from the College of the Holy Cross and a Master of Accountancy in Accounting from Boston College.
About SS Innovation
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger portion of the global population. The company’s product line includes its proprietary “SSI Mantra” surgical robotic system and its comprehensive suite of “SSI Mudra” surgical instruments, which support a variety of surgical robotic procedures, including cardiac surgery. SS Innovations, an American company headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly and cost-effective surgical robotic solutions. Visit Company Website ssinnovations.com Or Linkedin For more information and updates.
About SSI Mantra
SSI Mantra is a user-friendly, modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-face ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient-related information displays, a virtual real-time image of the robotic patient side arm cart, and the ability for superimposition of 3D models to diagnostic imaging. The optional SSI MantraSurgeon Tele-Surgeon Console is a portable, compact alternative to SSI Mantra’s standard Surgeon Command Center that provides equivalent control functionality while enabling advanced portability, ergonomic flexibility and telesurgery capability. SSI Mantra uses over 40 different types of robotic endo-surgical instruments to support various specialties including cardiac surgery, and 5 mm instruments for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon, providing improved safety and efficiency. SSI Mantra has been clinically validated in over 170 different types of surgical procedures in India.
forward-looking statements
This press release may contain statements that are not historical facts and that are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “believe,” “estimate,” “expect,” “will,” “intend,” “could,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “target” or the negative of such words or other similar expressions are used to identify such forward-looking statements. These statements relate to future events or the future financial performance of SS Innovations and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
equity group
Kalle Ahal, CFA
T: (303) 953-9878
Devin Sullivan, Managing Director
T: (212) 836-9608
media Contact:
RooneyPartners LLC
kate barrett
T: (212) 223-0561
Corporate Communications:
ibn.ai
Austin, Texas
512.354.7000 office